Released May 4, 2011, after the close
10-Q filed May 4, 2011, 34 days after period end · 0000950123-11-044803
Q1 2011 · 10-Q
Revenue—
Net Income-$5.05M-$5.05M no prior Q1 2010 on fileno prior Q4 2010 on file
EPS Diluted$0.06$0.06 no prior Q1 2010 on fileno prior Q4 2010 on file
Operating Cash Flow-$3,988,000—
Free Cash Flowderived-$6,592,000—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q1 2010 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protalix BioTherapeutics, Inc. · CIK 1006281 · Engraved from SEC EDGAR